1. Home
  2. YHC vs QNCX Comparison

YHC vs QNCX Comparison

Compare YHC & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LQR House Inc.

YHC

LQR House Inc.

HOLD

Current Price

$0.78

Market Cap

19.2M

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$0.93

Market Cap

19.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YHC
QNCX
Founded
2021
2012
Country
United States
United States
Employees
4
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.2M
19.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
YHC
QNCX
Price
$0.78
$0.93
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
388.7K
1.4M
Earning Date
04-15-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.88
Revenue
N/A
N/A
Revenue This Year
$1,267.57
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.33
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.08
52 Week High
$11.14
$4.55

Technical Indicators

Market Signals
Indicator
YHC
QNCX
Relative Strength Index (RSI) 42.42 41.03
Support Level $0.76 $0.79
Resistance Level $1.03 $0.98
Average True Range (ATR) 0.13 0.09
MACD -0.01 -0.03
Stochastic Oscillator 41.07 12.79

Price Performance

Historical Comparison
YHC
QNCX

About YHC LQR House Inc.

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Share on Social Networks: